Sycomore Asset Management Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sycomore Asset Management lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 63.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,866 shares of the medical equipment provider's stock after acquiring an additional 5,746 shares during the period. Sycomore Asset Management's holdings in Intuitive Surgical were worth $7,230,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock valued at $177,000 after acquiring an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. boosted its holdings in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after acquiring an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC boosted its holdings in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock valued at $653,000 after acquiring an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC boosted its holdings in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock valued at $310,000 after acquiring an additional 23 shares during the last quarter. Finally, Falcon Wealth Planning boosted its holdings in Intuitive Surgical by 0.4% in the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider's stock valued at $2,797,000 after acquiring an additional 23 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 in the last ninety days. Company insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Redburn Atlantic raised Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their price target for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Finally, Barclays boosted their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an "overweight" rating in a research note on Thursday, July 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $513.74.

Intuitive Surgical Stock Up 0.2 %

NASDAQ:ISRG traded up $1.11 during trading hours on Thursday, hitting $537.80. 1,908,278 shares of the company traded hands, compared to its average volume of 1,461,343. The firm's 50-day simple moving average is $496.95 and its 200-day simple moving average is $455.65. Intuitive Surgical, Inc. has a one year low of $291.39 and a one year high of $544.38. The company has a market cap of $191.55 billion, a PE ratio of 86.28, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.